Abiomed Receives Close-Out Letter From Food and Drug Administration

[at noodls] – DANVERS, Mass., Feb. 20, 2013 (GLOBE NEWSWIRE) — Abiomed, Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, today announced that on February 19, 2013, Abiomed received … more

View todays social media effects on ABMD

View the latest stocks trending across Twitter. Click to view dashboard

See who ABIOMED is hiring next, click here to view